667 related articles for article (PubMed ID: 28487847)
1. Recombinant
Czarnewski P; Araújo ECB; Oliveira MC; Mineo TWP; Silva NM
Front Cell Infect Microbiol; 2017; 7():142. PubMed ID: 28487847
[No Abstract] [Full Text] [Related]
2. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
3. Prime-boost vaccination with toxoplasma lysate antigen, but not with a mixture of recombinant protein antigens, leads to reduction of brain cyst formation in BALB/c mice.
Wagner A; Schabussova I; Ruttkowski B; Peschke R; Kur J; Kundi M; Joachim A; Wiedermann U
PLoS One; 2015; 10(5):e0126334. PubMed ID: 26010355
[TBL] [Abstract][Full Text] [Related]
4. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
[TBL] [
